SEC Form 4 · accession 0001209191-17-046510
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas S Ingram
Officer — President & CEO · Director
Period of report
Jul 27, 2017
Accepted (ET)
Jul 28, 2017 · 8:51 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2017 | P | 47,058 | $42.50 | A | 382,058 | D |
Table II — derivative securities
No Table II lines on this filing.